Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
SYStryker Corporation logo

Stryker Corporation (SYK)

New York Stock Exchange · Currency in USD
$307.15 ▲ +0.07 (+0.02%)
At close: Oct 23, 4:01 PM ET. Market closed.
$306.50 ▼ -0.65 (-0.21%)
After hours: Oct 23, 4:30 PM ET

Summary

Previous Close
$307.09
Open
$306.05
Day's Range
$305.00 – $309.57
52 Week Range
$267.00 – $389.33
Volume
1,984,803
Avg. Volume
2,650,578
Market Cap
$117.81B
Beta (5Y Monthly)
0.78
PE Ratio (TTM)
31.57
EPS (TTM)
$9.72
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
$3.52 (1.15%)
Ex-Dividend Date
Sep 30, 2026
1y Target Est
$365.89

Profile: Stryker Corporation

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
56,000
CEO
Kevin A. Lobo

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions.

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $3.55 · Revenue est. $6.62B
DateEst.Actual
Jul 30, 2026$3.49$3.69Beat
Apr 30, 2026$2.98$2.60Miss
Jan 29, 2026$4.40$4.47Beat
Oct 30, 2025$3.13$3.19Beat
Jul 31, 2025$3.07$3.13Beat
May 1, 2025$2.71$2.84Beat

Analyst view

Consensus price target
$365.89 ▲ +19.1%
Range $310.00 – $420.00
Rating: Buy
Buy 71% · Hold 29% · Sell -0%

Get free alerts on SYK and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.